These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8115668)

  • 41. Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.
    Noguera R; Altuna R; Alvarez E; Ayuso JL; Casais L; Udina C
    J Affect Disord; 1991 Jul; 22(3):119-24. PubMed ID: 1918655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trazodone for antidepressant-associated insomnia.
    Nierenberg AA; Adler LA; Peselow E; Zornberg G; Rosenthal M
    Am J Psychiatry; 1994 Jul; 151(7):1069-72. PubMed ID: 8010365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What constitutes an adequate antidepressant trial for fluoxetine?
    Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
    J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.
    Heiligenstein JH; Tollefson GD; Faries DE
    J Affect Disord; 1994 Mar; 30(3):163-73. PubMed ID: 8006243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.
    Nelson JC; Portera L; Leon AC
    J Clin Psychiatry; 2005 Nov; 66(11):1409-14. PubMed ID: 16420078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluoxetine-induced sexual dysfunction reversed by trazodone.
    Michael A; O'Donnell EA
    Can J Psychiatry; 2000 Nov; 45(9):847-8. PubMed ID: 11143841
    [No Abstract]   [Full Text] [Related]  

  • 48. Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
    Bruder GE; Stewart JW; McGrath PJ; Deliyannides D; Quitkin FM
    Neuropsychopharmacology; 2004 Sep; 29(9):1752-61. PubMed ID: 15238992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prophylactic efficacy of fluoxetine in unipolar depression.
    Montgomery SA; Dufour H; Brion S; Gailledreau J; Laqueille X; Ferrey G; Moron P; Parant-Lucena N; Singer L; Danion JM
    Br J Psychiatry Suppl; 1988 Sep; (3):69-76. PubMed ID: 3150694
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study].
    Cabras PL; Enriques E; Casini A; Paoletti C; Zagnoni P
    Minerva Psichiatr; 1991; 32(2):93-101. PubMed ID: 1870418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
    Rabkin JG; Wagner GJ; Rabkin R
    Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluoxetine in patients with major depressive disorder--a responder analysis.
    Klieser E; Lehmann E; Heinrich K
    Pharmacopsychiatry; 1995 Jan; 28(1):14-9. PubMed ID: 7746839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled comparison of milnacipran and fluoxetine in major depression.
    Ansseau M; Papart P; Troisfontaines B; Bartholomé F; Bataille M; Charles G; Schittecatte M; Darimont P; Devoitille JM; De Wilde J
    Psychopharmacology (Berl); 1994 Feb; 114(1):131-7. PubMed ID: 7846195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effects of serotonin uptake inhibitors in depression.
    Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
    J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experiences with doxepin and trazodone in the therapy with outpatients suffering from depression.
    Pöldinger W
    Psychopathology; 1984; 17 Suppl 2():30-6. PubMed ID: 6371876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.
    Haria M; Fitton A; McTavish D
    Drugs Aging; 1994 Apr; 4(4):331-55. PubMed ID: 8019056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
    Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.